Since it was reported that the noncanonical WNT pathway involving JNK activation had been implicated in fatty liver disease [11,14], we wanted to study the hepatic relative mRNA expression of WNT5A and JNK to add new knowledge about the role of this pathway in NAFLD pathogenesis. The gene discussed is WNT5A; the disease is metabolic dysfunction-associated steatotic liver disease.